The invention relates to sulfonamido-macrocycles according to the general Formula I and the salts thereof, to pharmaceutical compositions comprising the sulfonamido-macrocycles and to a method of preparing the sulfonamido-macrocycles as well as the use thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with angiopoietin and therefore influence Tie2 signalling.
wherein R1, R2, R4, A, X, Y, Z and m have the meaning as given in the specification and the claims.
该发明涉及根据一般式I和其盐的
磺胺基大环化合物,包括含有
磺胺基大环化合物的药物组合物,以及制备
磺胺基大环化合物的方法以及用于制造治疗血管生长失调疾病或伴随血管生长失调的疾病的药物组合物的用途,其中这些化合物有效干扰血管生成素,从而影响Tie2信号传导,其中R1、R2、R4、A、X、Y、Z和m的含义如规范和权利要求中所述。